SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012864
Filing Date
2020-11-05
Accepted
2020-11-05 16:17:41
Documents
82
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q chrs-20200930x10q.htm   iXBRL 10-Q 2740510
2 EX-31.1 chrs-20200930xex31d1.htm EX-31.1 13899
3 EX-31.2 chrs-20200930xex31d2.htm EX-31.2 14817
4 EX-32.1 chrs-20200930xex32d1.htm EX-32.1 12458
  Complete submission text file 0001558370-20-012864.txt   10575147

Data Files

Seq Description Document Type Size
5 EX-101.SCH chrs-20200930.xsd EX-101.SCH 66801
6 EX-101.CAL chrs-20200930_cal.xml EX-101.CAL 102502
7 EX-101.DEF chrs-20200930_def.xml EX-101.DEF 235379
8 EX-101.LAB chrs-20200930_lab.xml EX-101.LAB 584463
9 EX-101.PRE chrs-20200930_pre.xml EX-101.PRE 442004
10 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20200930x10q_htm.xml XML 2092459
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36721 | Film No.: 201290684
SIC: 2836 Biological Products, (No Diagnostic Substances)